BCLC-B hepatocellular carcinoma treatment or when should the systemic therapy be started

Choice of the optimal therapy for BCLC-B hepatocellular carcinoma (HCC) is a significant clinical problem. Transarterial chemoembolisation (TACE) is considered to be the method of choice as this approach is reported to produce a direct effect and to have a significant survival rate. However, TACE is...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: V. V. Breder, M. U. Pitkevich, E. R. Virshke, L. A. Kostyakova, I. A. Dzhanyan, K. K. Laktionov
स्वरूप: Artigo
भाषा:Russo
प्रकाशित: Remedium Group LLC 2018-07-01
श्रृंखला:Медицинский совет
विषय:
hepatocellular carcinoma
hcc
transarterial chemoembolization (tace)
sorafenib
regorafenib
bclc
ऑनलाइन पहुंच:https://www.med-sovet.pro/jour/article/view/2529
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन